These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 427759

  • 1. Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.
    Chou TC, Burchenal JH, Fox JJ, Watanabe KA, Chu CK, Philips FS.
    Cancer Res; 1979 Mar; 39(3):720-8. PubMed ID: 427759
    [Abstract] [Full Text] [Related]

  • 2. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 3. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S, Rauscher F, Jakubowski A, Cadman E.
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [Abstract] [Full Text] [Related]

  • 4. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG, Behrens M, Abraham D.
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside.
    Burchenal JH, Ciovacco K, Kalaher K, O'Toole T, Kiefner R, Dowling MD, Chu CK, Watanabe KA, Wempen I, Fox JJ.
    Cancer Res; 1976 Apr; 36(4):1520-3. PubMed ID: 1260769
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A, Leclerc JM, Dutschman G, Cooney D, Cheng YC.
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of alkylesters of 1-beta-D-ribofuranosyl-5-fluorouracil-5'-phosphate against murine lymphoma L5178Y resistant to 1-beta-D-ribofuranosyl-5-fluorouracil.
    Kanzawa F, Hoshi A, Kuretani K.
    Bull Cancer; 1979 Aug; 66(5):497-501. PubMed ID: 554675
    [Abstract] [Full Text] [Related]

  • 10. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
    Mulkins MA, Heidelberger C.
    Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 12. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
    Grant S, Cadman E.
    Cancer Res; 1980 Nov 15; 40(11):4000-6. PubMed ID: 6162541
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ, Pavelic ZP, Leonard RJ, Bloch A, Grindey GB.
    Cancer Res; 1980 Mar 15; 40(3):598-603. PubMed ID: 7471080
    [Abstract] [Full Text] [Related]

  • 14. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J, Cooney DA, Dalal M, Kang GJ, Cupp JE, DeClercq E, Broder S, Johns DG.
    Mol Pharmacol; 1987 Dec 15; 32(6):798-806. PubMed ID: 2826994
    [Abstract] [Full Text] [Related]

  • 15. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 16. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul 15; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1992 May 15; 52(10):2782-90. PubMed ID: 1316227
    [Abstract] [Full Text] [Related]

  • 18. Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine.
    Woodcock TM, Chou TC, Tan CT, Sternberg SS, Philips FS, Young CW, Burchenal JH.
    Cancer Res; 1980 Nov 15; 40(11):4243-9. PubMed ID: 7471064
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
    Ardalan B, Cooney DA, Jayaram HN, Carrico CK, Glazer RI, Macdonald J, Schein PS.
    Cancer Res; 1980 May 15; 40(5):1431-7. PubMed ID: 6245793
    [Abstract] [Full Text] [Related]

  • 20. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW, Major PP, Munroe D, Egan M, Herrick D.
    Cancer Res; 1983 May 15; 43(5):2000-4. PubMed ID: 6831429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.